(Q41858218)

English

Presymptomatic diagnosis with MRI and adequate treatment ameliorate the outcome after natalizumab-associated progressive multifocal leukoencephalopathy

scientific article published on 18 February 2013

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

13 October 2017

Presymptomatic diagnosis with MRI and adequate treatment ameliorate the outcome after natalizumab-associated progressive multifocal leukoencephalopathy (English)

1 reference

Europe PubMed Central

PMC publication ID

13 October 2017

author name string

Hans Lindå

1

1 reference

Europe PubMed Central

PMC publication ID

13 October 2017

Anders von Heijne

2

1 reference

Europe PubMed Central

PMC publication ID

13 October 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

18 February 2013

1 reference

Europe PubMed Central

PMC publication ID

13 October 2017

Frontiers in Neurology

1 reference

Europe PubMed Central

PMC publication ID

13 October 2017

4

1 reference

Europe PubMed Central

PMC publication ID

13 October 2017

11

1 reference

Europe PubMed Central

PMC publication ID

13 October 2017

Mefloquine improved progressive multifocal leukoencephalopathy in a patient with systemic lupus erythematosus

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3575071

5 June 2018

Risk of natalizumab-associated progressive multifocal leukoencephalopathy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3575071

5 June 2018

Identification and characterization of mefloquine efficacy against JC virus in vitro

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3575071

5 June 2018

Effect of plasma exchange in accelerating natalizumab clearance and restoring leukocyte function

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3575071

5 June 2018

PML-IRIS in patients with HIV infection: clinical manifestations and treatment with steroids

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3575071

5 June 2018

Evaluation of patients treated with natalizumab for progressive multifocal leukoencephalopathy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3575071

5 June 2018

A randomized, placebo-controlled trial of natalizumab for relapsing multiple sclerosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3575071

5 June 2018

Progressive multifocal leukoencephalopathy complicating treatment with natalizumab and interferon beta-1a for multiple sclerosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3575071

5 June 2018

Progressive multifocal leukoencephalopathy in a patient treated with natalizumab

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3575071

5 June 2018

New insights into progressive multifocal leukoencephalopathy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3575071

5 June 2018

The earlier, the smaller, the better for natalizumab-associated PML: in MRI vigilance veritas?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3575071

18 August 2018

MRI preclinical detection and asymptomatic course of a progressive multifocal leucoencephalopathy (PML) under natalizumab therapy.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3575071

18 August 2018

Successful management of natalizumab-associated progressive multifocal leukoencephalopathy and immune reconstitution syndrome in a patient with multiple sclerosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3575071

18 August 2018

Progressive multifocal leukoencephalopathy after natalizumab monotherapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3575071

18 August 2018

Treatment of progressive multifocal leukoencephalopathy associated with natalizumab

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3575071

18 August 2018

Neocortical atrophy, third ventricular width, and cognitive dysfunction in multiple sclerosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3575071

18 August 2018

Immune reconstitution inflammatory syndrome in the CNS of HIV-infected patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3575071

18 August 2018

Immune surveillance in multiple sclerosis patients treated with natalizumab.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3575071

18 August 2018

Natalizumab plus interferon beta-1a for relapsing multiple sclerosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3575071

18 August 2018

Thalamic atrophy and cognition in multiple sclerosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/23423248

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Progressive multifocal leukoencephalopathy

1 reference

https://pubmed.ncbi.nlm.nih.gov/23423248

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Steroids for PML-IRIS: a double-edged sword?

1 reference

https://pubmed.ncbi.nlm.nih.gov/23423248

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical outcomes of natalizumab-associated progressive multifocal leukoencephalopathy

1 reference

https://pubmed.ncbi.nlm.nih.gov/23423248

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Natalizumab-associated PML identified in the presymptomatic phase using MRI surveillance

1 reference

https://pubmed.ncbi.nlm.nih.gov/23423248

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.3389/FNEUR.2013.00011

1 reference

Europe PubMed Central

PMC publication ID

13 October 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

13 October 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

13 October 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q41858218&oldid=1928938389"